AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
“Younger people are getting cancer more and more. We have to make kinder medicines.”
2
Shipping giant MSC submits bid for ZIM, challenging Hapag-Lloyd in takeover race
3
The $2.3 billion mystery arms deal Israel won’t explain
4
“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”
5
Armis sale to ServiceNow could yield $4 billion windfall for Insight Partners
More news

Teva

20 stories about Teva
הפגנה עובדי טבע קריית שמונה

Kibbutz-Owned Food Manufacturer Maabarot Bids for Teva’s North Israel Facility

16.10.18|Golan Hazani
Last week, Calcalist reported that Teva was nearing the sale of its Kiryat Shmona facility to German pharmaceutical device company B. Braun
הפגנה עובדי טבע קריית שמונה

Teva Nearing Sale of Israeli Manufacturing Plant

09.10.18|Golan Hazani
The pharmaceutical company is negotiating the sale of a manufacturing facility located in the town Kiryat Shmona in the north of Israel
קאר שולץ מנכל טבע

Teva Investors Are Back on the Rollercoaster

27.09.18|Lilach Baumer
The stock of Teva Pharmaceutical Industries Ltd. fell over 11% on NYSE between September 20 and Thursday, bringing a halt to a nearly two weeks rally
קאר שולץ מנכל טבע

Teva Shares Rise Following FDA Approval of Migraine Drug

16.09.18|Dror Reich
Teva’s new migraine drug is forecasted to bring in $500 million in sales annually
קאר שולץ מנכל טבע

Available Cash Prompts Teva to Make $400 Million Debt Tender Offer

05.09.18|Lilach Baumer
The drugmaker is offering to pay senior notes due 2019 and 2020 in cash
הפגנה מפגינים פיטורים טבע אשדוד

Teva Outsources Manufacturing in Anticipation of Israeli Plant Closure

27.08.18|Golan Hazani
The debt-laden drugmaker announced an aggressive reorganization plan in December, consisting of wide-spread asset divestments and layoffs, including in its home country of Israel
תלמידים כיתה בית ספר לימודים ילדים

Teva’s EpiPen Won’t Hit U.S. Market in Time for School Year, Report Says

26.08.18|Dror Reich
The Israeli drugmaker received approval for a first generic version of Mylan’s auto-injector earlier this month
מטה טבע פתח תקווה

Teva Wins FDA Approval for First Generic EpiPen

19.08.18|Lilach Baumer
EpiPens were sold for less than $60 when Mylan acquired the injectors in 2007. Market Monopoly enabled the company to hike its price up to around $300 a unit today
וורן באפט אסיפת בעלי המניות מאי 2018

Berkshire Hathaway Builds Teva Position for Third Quarter in a Row

15.08.18|Lilach Baumer
In a Tuesday Filing, Warren Buffett’s holding company revealed it has increased its stake in Teva by 6.7% in the second quarter of 2018
ג'ול Juul סיגריה אלקטרונית

CTech’s Weekly Roundup of Israeli Tech News

10.08.18|CTech
Israel expected to ban marketing of e-cigarette Juul. Teva's American dream boat is sinking.
קאר שולץ מנכל טבע

Teva's American Dream Boat is Sinking

08.08.18|Uri Tal-Tene
Over the past six quarters Teva's North American sales have been in free fall. The company's operating profit is in even worse shape. Mylan's decision to slash the price tag on its generic Copaxone offering further threatens Teva's revenues, meaning the company must hurry to provide the three potential trump cards it has up its sleeve
קאר שולץ מנכל טבע

Teva Trending Down Following Underwhelming Second Quarter Revenues

02.08.18|Dror Reich
On Thursday, the generic drugmaker announced revenues that fell slightly short of analyst consensus
ועידת לונדון 2017 פרי דוידסון מייסד ו מנכל סייד מדיקל

Plants Are the Future of Medicine, Says Syqe Medical Founder

29.07.18|KPMG, a CTech partner
Transforming cannabis into precisely-dosed treatment has made it medically and financially legitimacy, says Perry Davidson, the founder of Syqe Medical, which developed a precise cannabis inhaler
אלרגן משרדים

Court Rules Allergan Can't Use Indian Tribe Deal to Protect Patents

23.07.18|CTech
In September 2017, Allergan transferred six of its patents for blockbuster dry eye drug Restasis to the St. Regis Mohawk Tribe, hoping to protect the patents under the principle of sovereign immunity
הפגנה הפגנת מחאת ה להט"ב חוק ה פונדקאות עזריאלי 3

Apple Hops on LGBT Support Wagon in Israel

22.07.18|Lilach Baumer
Crowds are currently marching in several Israeli cities, including Tel Aviv and Jerusalem, in protest of ongoing government discrimination against the LGBT community
ה מטה הנוכחי של טבע ב ארה"ב

Mylan Cuts Price of Generic Copaxone Offering by 60%

11.07.18|Lilach Baumer
Mylan has achieved a 15%-20% market share in the U.S. since launching its generic version in late 2017 with a monthly price tag of $5,000, compared to Teva's $5,800
קאר שולץ מנכל טבע

Teva to Relocate U.S. Headquarters to New Jersey

08.07.18|Lilach Baumer
In December, the Israeli drugmaker announced a far-reaching cost cutting plan to deal with its multi-billion debt
קאר שולץ מנכל טבע

Goldman Sachs Sees 16% Upside in Teva Stock

26.06.18|Dror Reich
Following a meeting with Teva’s management, the bank's analysts reiterated their "buy" recommendation with a higher target price
הפרות סדר עימותים ב גבול רצועת עזה גדר

CTech’s Weekly Roundup of Israeli Tech News

18.05.18|CTech
Israeli-made UAV dumps skunk-water on Gaza protesters. Homegrown content distribution company boosted the Israeli song ahead of Eurovision final.
מפעל טבע קריית שמונה

CTech’s Wednesday Roundup of Israeli Tech News

16.05.18|CTech
Credit Suisse to invest $250 Million in Israel-based life sciences venture fund aMoon. Mercedes to test autonomous electric sedan in Israel
Previous ArticlesMore Articles